New Zealand markets open in 1 hour 34 minutes

Prestige Consumer Healthcare Inc. (PBH)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
62.80+0.18 (+0.29%)
At close: 04:00PM EDT
62.80 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 3.13B
Enterprise value 4.22B
Trailing P/E 15.02
Forward P/E 14.10
PEG ratio (5-yr expected) 2.03
Price/sales (ttm)2.79
Price/book (mrq)1.89
Enterprise value/revenue 3.75
Enterprise value/EBITDA 11.28

Trading information

Stock price history

Beta (5Y monthly) 0.53
52-week change 310.44%
S&P500 52-week change 324.78%
52-week high 375.31
52-week low 352.90
50-day moving average 369.27
200-day moving average 363.51

Share statistics

Avg vol (3-month) 3247.58k
Avg vol (10-day) 3359.19k
Shares outstanding 549.92M
Implied shares outstanding 649.92M
Float 849.49M
% held by insiders 11.34%
% held by institutions 1105.13%
Shares short (15 May 2024) 41.58M
Short ratio (15 May 2024) 46.76
Short % of float (15 May 2024) 44.41%
Short % of shares outstanding (15 May 2024) 43.16%
Shares short (prior month 15 Apr 2024) 41.83M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 427 Dec 2013
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Mar 2024
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 18.60%
Operating margin (ttm)29.66%

Management effectiveness

Return on assets (ttm)6.41%
Return on equity (ttm)13.50%

Income statement

Revenue (ttm)1.13B
Revenue per share (ttm)22.62
Quarterly revenue growth (yoy)-3.10%
Gross profit (ttm)N/A
EBITDA 373.1M
Net income avi to common (ttm)209.34M
Diluted EPS (ttm)4.17
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)46.47M
Total cash per share (mrq)0.93
Total debt (mrq)1.14B
Total debt/equity (mrq)68.86%
Current ratio (mrq)3.20
Book value per share (mrq)33.22

Cash flow statement

Operating cash flow (ttm)248.93M
Levered free cash flow (ttm)177.04M